The splicing factor epithelial splicing regulatory protein 1 has been shown to promote endocrine resistance and confer poor prognosis to patients with ER+ breast carcinoma by affecting lipid metabolism including the expression of FASN [16]. The gene discussed is ESR1; the disease is breast carcinoma.